Key result
Patients over 75 years old with acute coronary syndrome experienced significantly longer total ischemia time compared to younger patients (466 vs. 322 minutes, p<0.001).
Why the study?
Patients over 75 years with acute coronary syndrome are underrepresented in clinical trials and face higher mortality, which is associated with treatment delays.
Does age over 75 years increase treatment delays in patients presenting with acute coronary syndrome for primary percutaneous coronary angioplasty?
Observational (n=833)
No
Does age over 75 years increase treatment delays in patients presenting with acute coronary syndrome for primary percutaneous coronary angioplasty?
Patients over 75 years of age with acute coronary syndrome experience significantly longer treatment delays, including first medical contact to wire and total ischemia times, highlighting the need for targeted interventions to improve timely care in this population.
Answers are grounded in this paper and cite their sources.
Longer treatment delays in elderly ACS patients were associated with higher mortality; leaves open whether targeted interventions narrow this gap.
The increase in life expectancy is leading to a progressively aging population in Western countries. Approximately one-third of patients (pts) hospitalised for acute coronary syndrome are over 75 years of age, who are underrepresented in randomised controlled trials, and have ahigher mortality rate. The mortality in pts presenting with an acute coronary syndrome is associated with many factors such as the time delay to treatment. Hence, we aim to analyse delays in the emergent coronary referral pathway for our centre taking age in consideration. Methods and Results: We conducted a retrospective analysis of 833 consecutive pts for primary percutaneous coronary angioplasty between January 2022 and April 2025. The median age was 64 ± 14 years, with 73% being male. Comorbidities included diabetes (27%), dyslipidemia (39%), hypertension (56%), smoking (48%), family history of cardiac disease (5%), and prior myocardial infarction (12%). The time variables analyzed included patient, ECG, diagnostic, transport and home delay, and procedure time. Additional variables were door-in-door-out, diagnosis-to-wire, first medical contact (FMC) to wire, and total ischemia time. Pts over 75 years old were less frequently male (60% vs. 77%, p<0.001), had lower smoking history (14% vs. 58%, p<0.001), and family history of cardiac disease (1% vs. 6%, p=0.006). Conversely, they exhibited higher rates of diabetes (33% vs. 25%, p=0.030), dyslipidemia (48% vs 36%, p=0.003), and hypertension (70% vs 51%, p<0.001). No significant differences were found regarding median patient (106 min vs. 101 min, p=0.069), transport (105 min vs. 86 min, p=0.263) or home delay (2 min vs. 2 min, p=0.269), diagnosis-to-wire time (150 min vs. 122 min, p=0.098), or procedure time (61 min vs. 57 min, p=0.183). However, older pts demonstrated significantly longer ECG (22 min vs. 14 min, p<0.001) and diagnostic delay (40 min vs. 22 min, p<0.001), door-in-door-out (150 min vs. 76 min, p<0.001), FMC to wire time (262 min vs. 174 min, p<0.001), and total ischemia time (466 min vs. 322 min, p<0.001). After adjustment for cardiovascular risk factors, age over 75 years was identified as an independent predictor of prolonged ECG delay (p=0.018), door-in-door-out time (p=0.004), and FMC to wire time (p=0.001). Conclusions: This study shows that our population is significantly delayed compared ESC guidelines gola, indicating that increased education and awareness are essential to reduce delays. Pts over 75, experienced longer delays in ECG, diagnostic and overall treatment times. Despite no difference in certain delays such as patient and transport times, factors like diabetes, dyslipidemia, and hypertension were more prevalent in this age group, further complicating timely care. Addressing these delays through targeted interventions focusing on older pts could help reduce treatment times, ultimately improving clinical outcomes for those affected by acute coronary syndrome.
No takes yet. Share an insight, caveat, or question.
Viana et al. (2026) conducted an observational in Acute coronary syndrome (n=833). Age > 75 years vs. Age ≤ 75 years was evaluated on Total ischemia time (minutes) (p=<0.001). Patients over 75 years old with acute coronary syndrome experienced significantly longer total ischemia time compared to younger patients (466 vs. 322 minutes, p<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: